Insmed, Inc. (INSM)
121.21
+2.67
(+2.25%)
USD |
NASDAQ |
Aug 31, 15:33
Insmed Cash and Short Term Investments (Quarterly) : 1.160B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.160B |
| March 31, 2026 | 1.224B |
| December 31, 2025 | 1.430B |
| September 30, 2025 | 1.680B |
| June 30, 2025 | 1.857B |
| March 31, 2025 | 1.199B |
| December 31, 2024 | 1.434B |
| September 30, 2024 | 1.468B |
| June 30, 2024 | 1.247B |
| March 31, 2024 | 595.73M |
| December 31, 2023 | 780.45M |
| September 30, 2023 | 785.95M |
| June 30, 2023 | 917.77M |
| March 31, 2023 | 998.68M |
| December 31, 2022 | 1.148B |
| September 30, 2022 | 513.30M |
| June 30, 2022 | 554.87M |
| March 31, 2022 | 635.12M |
| December 31, 2021 | 716.78M |
| September 30, 2021 | 846.56M |
| June 30, 2021 | 928.33M |
| March 31, 2021 | 409.75M |
| December 31, 2020 | 532.76M |
| September 30, 2020 | 588.75M |
| June 30, 2020 | 641.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 428.94M |
| December 31, 2019 | 487.43M |
| September 30, 2019 | 535.63M |
| June 30, 2019 | 601.26M |
| March 31, 2019 | 420.23M |
| December 31, 2018 | 495.07M |
| September 30, 2018 | 567.57M |
| June 30, 2018 | 634.33M |
| March 31, 2018 | 686.58M |
| December 31, 2017 | 381.16M |
| September 30, 2017 | 430.68M |
| June 30, 2017 | 91.06M |
| March 31, 2017 | 125.84M |
| December 31, 2016 | 162.59M |
| September 30, 2016 | 200.52M |
| June 30, 2016 | 223.11M |
| March 31, 2016 | 252.87M |
| December 31, 2015 | 282.88M |
| September 30, 2015 | 310.97M |
| June 30, 2015 | 335.03M |
| March 31, 2015 | 134.55M |
| December 31, 2014 | 159.23M |
| September 30, 2014 | 167.31M |
| June 30, 2014 | 82.70M |
| March 31, 2014 | 101.25M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Biogen, Inc. | 1.285B |
| Gilead Sciences, Inc. | 4.882B |
| Agios Pharmaceuticals, Inc. | 617.58M |